Kiwi Wealth Investments Limited Partnership Ultragenyx Pharmaceutical Inc. Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $488,147 - $970,269	-12,552 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$71.81 - $90.15 $901,359 - $1.13 Million	12,552 New	12,552 $958,000

Others Institutions Holding RARE

# of Institutions

345

Shares Held

86.7M

Call Options Held

675K

Put Options Held

846K

Vanguard Group Inc Valley Forge, PA

10M
Shares

$393 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$220 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

4.3M
Shares

$168 Million
0.57% of portfolio
State Street Corp Boston, MA

2.72M
Shares

$107 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.51M
Shares

$98.4 Million
0.01% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.74B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account